Behandlingsniveau og behandlingsstop ved benign lungesygdom

Anita Rath Sørensen, Elisabeth Bendstrup, Anders Løkke, Ingrid Louise Titlestad, Jens Ulrik Jensen, Laura Thomsen, Nassim Roberts, Pia Gjørup, Saher Shaker, Svend Gundestrup, Torgny Wilcke, Ulla Møller Weinreich, Kristoffer Marsaa


The decision to limit or discontinue treatment is a difficult issue, which all physicians will face. Timely communication with information on treatment possibilities and limitations, respectful listening to patients' and informal caregivers' wishes and early palliation is recommended in a stable phase. In some situations, it is better to stop life-prolonging treatment and optimise quality of life in patients with benign pulmonary diseases. Decision on treatment limitations or discontinuation is best taken at a conference and should be based on the patient's wishes, the disease stage and progression and potential reversible components.

Bidragets oversatte titelTreatment limitations or discontinuation in patients with benign pulmonary diseases
TidsskriftUgeskrift for Laeger
Udgave nummer39
StatusUdgivet - 24 sep. 2018


Dyk ned i forskningsemnerne om 'Behandlingsniveau og behandlingsstop ved benign lungesygdom'. Sammen danner de et unikt fingeraftryk.